3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Papillomavirus Infections
1
Head and Neck Neoplasms
1
HIV Infections
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Fluorouracil
8
Cisplatin
5
Radiotherapy
4
Mitomycin
4
Light Coagulation
3
dehydroftorafur
2
Watchful Waiting
2
Taxes
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Cetuximab
2
Carboplatin
2
Capecitabine
2
Biopsy
2
Vorinostat
1
Specimen Handling
1
Polymerase Chain Reaction
1
Platinum
1
Octreotide
1
Observation
1
Mitozytrex
1
Magnetic Resonance Spectroscopy
1
Laser Therapy
1
Imiquimod
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Gene Expression Profiling
1
Fluorodeoxyglucose F18
1
DNA Methylation
1
Cidofovir
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Anus Neoplasms
×
Laser Therapy
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts